Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Depreciation & Amortization (CF): 2010-2024

Historic Depreciation & Amortization (CF) for CorMedix (CRMD) over the last 14 years, with Dec 2024 value amounting to $153,937.

  • CorMedix's Depreciation & Amortization (CF) rose 535.97% to $161,917 in Q3 2025 from the same period last year, while for Sep 2025 it was $464,631, marking a year-over-year increase of 421.63%. This contributed to the annual value of $153,937 for FY2024, which is 117.56% up from last year.
  • According to the latest figures from FY2024, CorMedix's Depreciation & Amortization (CF) is $153,937, which was up 117.56% from $70,755 recorded in FY2023.
  • CorMedix's Depreciation & Amortization (CF)'s 5-year high stood at $153,937 during FY2024, with a 5-year trough of $61,890 in FY2021.
  • In the last 3 years, CorMedix's Depreciation & Amortization (CF) had a median value of $84,618 in 2022 and averaged $103,103.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first slumped by 51.63% in 2021, then surged by 117.56% in 2024.
  • Yearly analysis of 5 years shows CorMedix's Depreciation & Amortization (CF) stood at $127,964 in 2020, then tumbled by 51.63% to $61,890 in 2021, then surged by 36.72% to $84,618 in 2022, then decreased by 16.38% to $70,755 in 2023, then spiked by 117.56% to $153,937 in 2024.